Two Sigma Advisers

Two Sigma Advisers’s Viridian Therapeutics VRDN Stock Holding History

Two Sigma Advisers’s Portfolio VRDN Stock Details VRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-93,800	Closed	-$1.31M	–	2654
2025 Q2	$1.31M	Sell	93,800 -99,500	-51%	-$1.35M	﹤0.01%	1308
2025 Q1	$2.61M	Sell	193,300 -142,269	-42%	-$2.42M	0.01%	1051
2024 Q4	$6.43M	Sell	335,569 -109,231	-25%	-$2.38M	0.01%	619
2024 Q3	$10.1M	Sell	444,800 -81,900	-16%	-$1.34M	0.02%	486
2024 Q2	$6.85M	Buy	526,700 +222,300	+73%	+$3.08M	0.02%	655
2024 Q1	$5.33M	Buy	304,400 +204,100	+203%	+$3.96M	0.01%	757
2023 Q4	$2.18M	Buy	100,300 +80,000	+394%	+$1.26M	0.01%	1240
2023 Q3	$311K	Buy	20,300 +10,800	+114%	+$206K	﹤0.01%	1968
2023 Q2	$226K	Buy	+9,500	New	+$244K	﹤0.01%	2062

Other funds holding VRDN

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return